Selected research
Market Analysis & Forecast
Global Single Molecule Real Time Sequencing Market Analysis and Forecast 2026-2032
Market perspective
The global Single Molecule Real Time Sequencing market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The North America market for Single Molecule Real Time Sequencing is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Europe market for Single Molecule Real Time Sequencing is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Read the full market overview
Asia-Pacific market for Single Molecule Real Time Sequencing is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The China market for Single Molecule Real Time Sequencing is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The major global companies of Single Molecule Real Time Sequencing include Pacific Biosciences, Oxford Nanopore Technologies Limited, MicrobesNG, Creative Biomart, BGI, GENEWIZ, Novogene and Macrogen, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.
Report Includes
This report presents an overview of global market for Single Molecule Real Time Sequencing, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.
This report researches the key producers of Single Molecule Real Time Sequencing, also provides the revenue of main regions and countries. Of the upcoming market potential for Single Molecule Real Time Sequencing, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Single Molecule Real Time Sequencing revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Single Molecule Real Time Sequencing market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Single Molecule Real Time Sequencing revenue, projected growth trends, production technology, application and end-user industry.
Single Molecule Real Time Sequencing Segment by Company
Pacific Biosciences
Oxford Nanopore Technologies Limited
MicrobesNG
Creative Biomart
BGI
GENEWIZ
Novogene
Macrogen
Single Molecule Real Time Sequencing Segment by Type
Pre-sequencing
Sequencing
Data Analysis
Single Molecule Real Time Sequencing Segment by Application
Academic & Research Institutes
Hospitals & Clinics
Pharmaceutical & Biotechnology Companies
Others
Single Molecule Real Time Sequencing Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key players, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Single Molecule Real Time Sequencing market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Single Molecule Real Time Sequencing and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Single Molecule Real Time Sequencing.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Revenue of Single Molecule Real Time Sequencing in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 4: Detailed analysis of Single Molecule Real Time Sequencing company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Single Molecule Real Time Sequencing revenue, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, revenue for each segment.
Chapter 9: Europe by type, by application and by country, revenue for each segment.
Chapter 10: China type, by application, revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.
Chapter 13: The main concluding insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Pre-sequencing
- Sequencing
- Data Analysis
Applications
- Academic & Research Institutes
- Hospitals & Clinics
- Pharmaceutical & Biotechnology Companies
- Others
Companies covered
- Pacific Biosciences
- Oxford Nanopore Technologies Limited
- MicrobesNG
- Creative Biomart
- BGI
- GENEWIZ
- Novogene
- Macrogen
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Single Molecule Real Time Sequencing Market by Type
- 1.2.1 Global Single Molecule Real Time Sequencing Market Size by Type, 2021 VS 2025 VS 2032
- 1.2.2 Pre-sequencing
- 1.2.3 Sequencing
- 1.2.4 Data Analysis
- 1.3 Single Molecule Real Time Sequencing Market by Application
- 1.3.1 Global Single Molecule Real Time Sequencing Market Size by Application, 2021 VS 2025 VS 2032
- 1.3.2 Academic & Research Institutes
- 1.3.3 Hospitals & Clinics
- 1.3.4 Pharmaceutical & Biotechnology Companies
- 1.3.5 Others
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Single Molecule Real Time Sequencing Market Dynamics
- 2.1 Single Molecule Real Time Sequencing Industry Trends
- 2.2 Single Molecule Real Time Sequencing Industry Drivers
- 2.3 Single Molecule Real Time Sequencing Industry Opportunities and Challenges
- 2.4 Single Molecule Real Time Sequencing Industry Restraints
3 Global Growth Perspective
- 3.1 Global Single Molecule Real Time Sequencing Market Perspective (2021-2032)
- 3.2 Global Single Molecule Real Time Sequencing Growth Trends by Region
- 3.2.1 Global Single Molecule Real Time Sequencing Market Size by Region: 2021 VS 2025 VS 2032
- 3.2.2 Global Single Molecule Real Time Sequencing Market Size by Region (2021-2026)
- 3.2.3 Global Single Molecule Real Time Sequencing Market Size by Region (2027-2032)
4 Competitive Landscape by Players
- 4.1 Global Single Molecule Real Time Sequencing Revenue by Players
- 4.1.1 Global Single Molecule Real Time Sequencing Revenue by Players (2021-2026)
- 4.1.2 Global Single Molecule Real Time Sequencing Revenue Market Share by Players (2021-2026)
- 4.1.3 Global Single Molecule Real Time Sequencing Players Revenue Share Top 10 and Top 5 in 2025
- 4.2 Global Single Molecule Real Time Sequencing Key Players Ranking, 2024 VS 2025 VS 2026
- 4.3 Global Single Molecule Real Time Sequencing Key Players Headquarters & Area Served
- 4.4 Global Single Molecule Real Time Sequencing Players, Product Type & Application
- 4.5 Global Single Molecule Real Time Sequencing Players Establishment Date
- 4.6 Market Competitive Analysis
- 4.6.1 Global Single Molecule Real Time Sequencing Market CR5 and HHI
- 4.6.3 2025 Single Molecule Real Time Sequencing Tier 1, Tier 2, and Tier 3
5 Single Molecule Real Time Sequencing Market Size by Type
- 5.1 Global Single Molecule Real Time Sequencing Revenue by Type (2021 VS 2025 VS 2032)
- 5.2 Global Single Molecule Real Time Sequencing Revenue by Type (2021-2032)
- 5.3 Global Single Molecule Real Time Sequencing Revenue Market Share by Type (2021-2032)
6 Single Molecule Real Time Sequencing Market Size by Application
- 6.1 Global Single Molecule Real Time Sequencing Revenue by Application (2021 VS 2025 VS 2032)
- 6.2 Global Single Molecule Real Time Sequencing Revenue by Application (2021-2032)
- 6.3 Global Single Molecule Real Time Sequencing Revenue Market Share by Application (2021-2032)
7 Company Profiles
- 7.1 Pacific Biosciences
- 7.1.1 Pacific Biosciences Company Information
- 7.1.2 Pacific Biosciences Business Overview
- 7.1.3 Pacific Biosciences Single Molecule Real Time Sequencing Revenue and Gross Margin (2021-2026)
- 7.1.4 Pacific Biosciences Single Molecule Real Time Sequencing Product Portfolio
- 7.1.5 Pacific Biosciences Recent Developments
- 7.2 Oxford Nanopore Technologies Limited
- 7.2.1 Oxford Nanopore Technologies Limited Company Information
- 7.2.2 Oxford Nanopore Technologies Limited Business Overview
- 7.2.3 Oxford Nanopore Technologies Limited Single Molecule Real Time Sequencing Revenue and Gross Margin (2021-2026)
- 7.2.4 Oxford Nanopore Technologies Limited Single Molecule Real Time Sequencing Product Portfolio
- 7.2.5 Oxford Nanopore Technologies Limited Recent Developments
- 7.3 MicrobesNG
- 7.3.1 MicrobesNG Company Information
- 7.3.2 MicrobesNG Business Overview
- 7.3.3 MicrobesNG Single Molecule Real Time Sequencing Revenue and Gross Margin (2021-2026)
- 7.3.4 MicrobesNG Single Molecule Real Time Sequencing Product Portfolio
- 7.3.5 MicrobesNG Recent Developments
- 7.4 Creative Biomart
- 7.4.1 Creative Biomart Company Information
- 7.4.2 Creative Biomart Business Overview
- 7.4.3 Creative Biomart Single Molecule Real Time Sequencing Revenue and Gross Margin (2021-2026)
- 7.4.4 Creative Biomart Single Molecule Real Time Sequencing Product Portfolio
- 7.4.5 Creative Biomart Recent Developments
- 7.5 BGI
- 7.5.1 BGI Company Information
- 7.5.2 BGI Business Overview
- 7.5.3 BGI Single Molecule Real Time Sequencing Revenue and Gross Margin (2021-2026)
- 7.5.4 BGI Single Molecule Real Time Sequencing Product Portfolio
- 7.5.5 BGI Recent Developments
- 7.6 GENEWIZ
- 7.6.1 GENEWIZ Company Information
- 7.6.2 GENEWIZ Business Overview
- 7.6.3 GENEWIZ Single Molecule Real Time Sequencing Revenue and Gross Margin (2021-2026)
- 7.6.4 GENEWIZ Single Molecule Real Time Sequencing Product Portfolio
- 7.6.5 GENEWIZ Recent Developments
- 7.7 Novogene
- 7.7.1 Novogene Company Information
- 7.7.2 Novogene Business Overview
- 7.7.3 Novogene Single Molecule Real Time Sequencing Revenue and Gross Margin (2021-2026)
- 7.7.4 Novogene Single Molecule Real Time Sequencing Product Portfolio
- 7.7.5 Novogene Recent Developments
- 7.8 Macrogen
- 7.8.1 Macrogen Company Information
- 7.8.2 Macrogen Business Overview
- 7.8.3 Macrogen Single Molecule Real Time Sequencing Revenue and Gross Margin (2021-2026)
- 7.8.4 Macrogen Single Molecule Real Time Sequencing Product Portfolio
- 7.8.5 Macrogen Recent Developments
8 North America
- 8.1 North America Single Molecule Real Time Sequencing Revenue (2021-2032)
- 8.2 North America Single Molecule Real Time Sequencing Revenue by Type (2021-2032)
- 8.2.1 North America Single Molecule Real Time Sequencing Revenue by Type (2021-2026)
- 8.2.2 North America Single Molecule Real Time Sequencing Revenue by Type (2027-2032)
- 8.3 North America Single Molecule Real Time Sequencing Revenue Share by Type (2021-2032)
- 8.4 North America Single Molecule Real Time Sequencing Revenue by Application (2021-2032)
- 8.4.1 North America Single Molecule Real Time Sequencing Revenue by Application (2021-2026)
- 8.4.2 North America Single Molecule Real Time Sequencing Revenue by Application (2027-2032)
- 8.5 North America Single Molecule Real Time Sequencing Revenue Share by Application (2021-2032)
- 8.6 North America Single Molecule Real Time Sequencing Revenue by Country
- 8.6.1 North America Single Molecule Real Time Sequencing Revenue by Country (2021 VS 2025 VS 2032)
- 8.6.2 North America Single Molecule Real Time Sequencing Revenue by Country (2021-2026)
- 8.6.3 North America Single Molecule Real Time Sequencing Revenue by Country (2027-2032)
- 8.6.4 United States
- 8.6.5 Canada
- 8.6.6 Mexico
9 Europe
- 9.1 Europe Single Molecule Real Time Sequencing Revenue (2021-2032)
- 9.2 Europe Single Molecule Real Time Sequencing Revenue by Type (2021-2032)
- 9.2.1 Europe Single Molecule Real Time Sequencing Revenue by Type (2021-2026)
- 9.2.2 Europe Single Molecule Real Time Sequencing Revenue by Type (2027-2032)
- 9.3 Europe Single Molecule Real Time Sequencing Revenue Share by Type (2021-2032)
- 9.4 Europe Single Molecule Real Time Sequencing Revenue by Application (2021-2032)
- 9.4.1 Europe Single Molecule Real Time Sequencing Revenue by Application (2021-2026)
- 9.4.2 Europe Single Molecule Real Time Sequencing Revenue by Application (2027-2032)
- 9.5 Europe Single Molecule Real Time Sequencing Revenue Share by Application (2021-2032)
- 9.6 Europe Single Molecule Real Time Sequencing Revenue by Country
- 9.6.1 Europe Single Molecule Real Time Sequencing Revenue by Country (2021 VS 2025 VS 2032)
- 9.6.2 Europe Single Molecule Real Time Sequencing Revenue by Country (2021-2026)
- 9.6.3 Europe Single Molecule Real Time Sequencing Revenue by Country (2027-2032)
- 9.6.4 Germany
- 9.6.5 France
- 9.6.6 U.K.
- 9.6.7 Italy
- 9.6.8 Russia
- 9.6.9 Spain
- 9.6.10 Netherlands
- 9.6.11 Switzerland
- 9.6.12 Sweden
- 9.6.13 Poland
10 China
- 10.1 China Single Molecule Real Time Sequencing Revenue (2021-2032)
- 10.2 China Single Molecule Real Time Sequencing Revenue by Type (2021-2032)
- 10.2.1 China Single Molecule Real Time Sequencing Revenue by Type (2021-2026)
- 10.2.2 China Single Molecule Real Time Sequencing Revenue by Type (2027-2032)
- 10.3 China Single Molecule Real Time Sequencing Revenue Share by Type (2021-2032)
- 10.4 China Single Molecule Real Time Sequencing Revenue by Application (2021-2032)
- 10.4.1 China Single Molecule Real Time Sequencing Revenue by Application (2021-2026)
- 10.4.2 China Single Molecule Real Time Sequencing Revenue by Application (2027-2032)
- 10.5 China Single Molecule Real Time Sequencing Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
- 11.1 Asia Single Molecule Real Time Sequencing Revenue (2021-2032)
- 11.2 Asia Single Molecule Real Time Sequencing Revenue by Type (2021-2032)
- 11.2.1 Asia Single Molecule Real Time Sequencing Revenue by Type (2021-2026)
- 11.2.2 Asia Single Molecule Real Time Sequencing Revenue by Type (2027-2032)
- 11.3 Asia Single Molecule Real Time Sequencing Revenue Share by Type (2021-2032)
- 11.4 Asia Single Molecule Real Time Sequencing Revenue by Application (2021-2032)
- 11.4.1 Asia Single Molecule Real Time Sequencing Revenue by Application (2021-2026)
- 11.4.2 Asia Single Molecule Real Time Sequencing Revenue by Application (2027-2032)
- 11.5 Asia Single Molecule Real Time Sequencing Revenue Share by Application (2021-2032)
- 11.6 Asia Single Molecule Real Time Sequencing Revenue by Country
- 11.6.1 Asia Single Molecule Real Time Sequencing Revenue by Country (2021 VS 2025 VS 2032)
- 11.6.2 Asia Single Molecule Real Time Sequencing Revenue by Country (2021-2026)
- 11.6.3 Asia Single Molecule Real Time Sequencing Revenue by Country (2027-2032)
- 11.6.4 Japan
- 11.6.5 South Korea
- 11.6.6 India
- 11.6.7 Australia
- 11.6.8 Taiwan
- 11.6.9 Southeast Asia
12 South America, Middle East and Africa
- 12.1 SAMEA Single Molecule Real Time Sequencing Revenue (2021-2032)
- 12.2 SAMEA Single Molecule Real Time Sequencing Revenue by Type (2021-2032)
- 12.2.1 SAMEA Single Molecule Real Time Sequencing Revenue by Type (2021-2026)
- 12.2.2 SAMEA Single Molecule Real Time Sequencing Revenue by Type (2027-2032)
- 12.3 SAMEA Single Molecule Real Time Sequencing Revenue Share by Type (2021-2032)
- 12.4 SAMEA Single Molecule Real Time Sequencing Revenue by Application (2021-2032)
- 12.4.1 SAMEA Single Molecule Real Time Sequencing Revenue by Application (2021-2026)
- 12.4.2 SAMEA Single Molecule Real Time Sequencing Revenue by Application (2027-2032)
- 12.5 SAMEA Single Molecule Real Time Sequencing Revenue Share by Application (2021-2032)
- 12.6 SAMEA Single Molecule Real Time Sequencing Revenue by Country
- 12.6.1 SAMEA Single Molecule Real Time Sequencing Revenue by Country (2021 VS 2025 VS 2032)
- 12.6.2 SAMEA Single Molecule Real Time Sequencing Revenue by Country (2021-2026)
- 12.6.3 SAMEA Single Molecule Real Time Sequencing Revenue by Country (2027-2032)
- 12.6.4 Brazil
- 12.6.5 Argentina
- 12.6.6 Chile
- 12.6.7 Colombia
- 12.6.8 Peru
- 12.6.9 Saudi Arabia
- 12.6.10 Israel
- 12.6.11 UAE
- 12.6.12 Turkey
- 12.6.13 Iran
- 12.6.14 Egypt
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst